Best Life Sciences Companies in Vaud, Switzerland

Developer of neurotherapeutic solutions combining behavior, software, devices, and data. The company offers a platform for brain health and recovery. It provides precision neurotherapeutics through a portfolio of solutions. The company also develops formulations for rare diseases. Its offerings include an immersive experience platform for brain recovery and a neurorehabilitation system. It provides a hand training peripheral and technology for digital motion assessments.

Funding rounds

• Feb 2022Series B$105M
• Feb 2022Grant (prize money)$12.1M
• Oct 2021Conventional Debt$125M
• Sep 2017Angel—

Founders & team

Tej TadiFounder & Co-CEOAlexandre CapetCo-CEO

Investors

Hinduja Group, AlbaCore Capital Group, Admin, Concord Health Partners, Salica Investments, Foundation Neuro.io

Tech stack

Amazon SesAmazon Web ServicesBootstrapCdnjsCloudflareCloudflare Bot Management

Developer of robotic devices for surgical procedures. It develops DEXTER, a hybrid surgical robot that simplifies robotic-assisted minimally invasive surgery for hospitals and outpatient settings. It consists of fully articulated, single-use 8 mm instruments for suturing and dissection, like needle drivers, Johann graspers, monopolar scissors, and bipolar Maryland forceps. The device also provides the option to switch between laparoscopic and robotic surgery at any time during surgery.

Funding rounds

• Jan 2026Series G—
• Nov 2025Series G$150M
• Sep 2024Series F—
• Apr 2023Series F$150M

Founders & team

Greg RocheCEOMichael FriedrichCOO

Investors

Revival Healthcare Capital, Swiss, 415 CAPITAL, Zühlke, BlueOcean Ventures, Johnson & Johnson

Tech stack

Apple Icloud MailAzureCloudflareCloudflare Bot ManagementGoogle AnalyticsGoogle Workspace

Developer of digital microscopy system for high-resolution imaging of tissue. The system allows rapid imaging of fresh tissue surfaces without slicing. It uses confocal microscopy for tissue visualization while preserving the specimen. The system includes a fluorescent stain and single-use device for imaging. Digital tools allow physicians to review images remotely and annotate areas of interest.

Funding rounds

• Jan 2026Series C$23.7M
• Apr 2025Series B$6M
• Jul 2024Series B$14M
• Aug 2021Grant (prize money)$59K

Founders & team

Etienne ShafferCTO & ex-Co-FounderOlivier DelporteCEO

Investors

FIT, EIC Fund, Panakes Partners, BOM, BtoV, Sioux

Tech stack

CloudflareCloudflare Bot ManagementHttp/3HubspotMicrosoft 365Next.Js

Provider of transcriptomics solutions for research and biomarker discovery. The company offers proprietary technology for RNA-seq of multiplex RNA samples for sequencing. The company also offers mRNA sequencing services and a kit that can be used for multiple samples.

Funding rounds

• Mar 2026Seed$3.9M
• Mar 2024Seed$3.2M
• Mar 2023Conventional Debt$539.1K
• May 2022Seed$1M

Founders & team

Daniel AlpernCo-FounderRiccardo DaineseCo-Founder

Investors

Novalis Biotech, TechU, Venture Kick, FIT, Zurcher Kantonalbank, Startup days

Tech stack

Apache Http ServerApple Icloud MailCdnjsCloudflareCloudflare Bot ManagementCookiebot

Developer of RNA-based therapies for treating heart diseases. It offers a platform that integrates multimodal functional genomics with computational tools to determine RNA-targeting modalities, such as modified antisense oligonucleotides (ASOs) to inhibit lncRNAs to prevent Fibrosis.

Funding rounds

• May 2025Series A$65M
• Feb 2022Seed$5M
• May 2021Seed$20M
• Nov 2017Grant (prize money)$40.3K

Founders & team

Samir OunzainCo-Founder & CEOThierry PedrazziniCo-FounderDaniel BlessingCo-Founder & CTO

Investors

Broadview Ventures, Apollo Health Ventures, 4see ventures, Schroders Capital, Viva BioInnovator, BERNINA BioInvest

Tech stack

Apache Http ServerCookieyesGsapHotjarHstsJquery

Developer of a surgical instrument for spinal surgeries. The company uses a proprietary Controlled-Fixation technology to design post-operative, balanced, and stable spine instruments. The company products inlcude Neo Pedicle Sccrew System, and Neo Cage System is used for thoracolumbar spinal fusion.

Funding rounds

• Sep 2024Series B$68M
• Feb 2022Series A$20.6M
• Jan 2022Seed—
• May 2020Seed$13.6M

Founders & team

Vincent LefauconnierCo-Founder & Co-CEOJonas LarssonCo-Founder & Co-CEO

Investors

Credit Suisse Entrepreneur Capital, Verve Ventures, Gyrus Capital, Boundary, Swisscom, Helvetica Capital

Tech stack

Backbone.JsBootstrapCloudflareCloudflare Bot ManagementCloudflare Browser InsightsCloudflare Rocket Loader

Developer of small molecules for the treatment of neurodegenerative diseases. The company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease.

Developer of technology for cancer precision medicine. It offers an Immuno-transcriptomic platform combined with machine learning and predictive algorithms that enables the identification of disease-specific mRNA signatures of immune cells and the progression of the disease. Its lead product, Colox a molecular test that measures the immune system's reaction to colorectal cancer.

Developer of a neurostimulator implant for treating male impotence. The company has developed CaverSTIM, implantable neurostimulator device. The device is implanted in the pelvic cavity to stimulate (using wireless remote control) the cavernous nerves for erection function.

Funding rounds

• Jul 2025Series A$9.4M
• Feb 2025Series A$4.8M
• Jan 2023Seed$921.5K
• Dec 2020Seed$1.4M

Founders & team

Rodrigo Fraga-SilvaCo-Founder & COO

Investors

Venture Kick, Zurcher Kantonalbank, Nest, Verve Ventures, Praxis, FIT

Provider of retinal imaging solutions for retinal disorders. By using the technology doctors can understand and visualize the origins of many diseases such as age-related macular degeneration. It allows the ophthalmologist to measure the cell density or size of the retina. It helps ophthalmologists to see the micro-vasculature structure and the small capillaries in retinal disorder.

Funding rounds

• Sep 2025Seed$3.9M
• Oct 2023Seed$111.3K
• May 2021Seed$2.6M
• Feb 2020Conventional Debt$102.9K

Founders & team

Francine Behar-CohenCo-FounderMathieu KunziCo-Founder & CTOTimothe LaforestCo-Founder & CEO

Investors

FIT, EIT Health, Verve Ventures, Nina Capital, Fongit, Nova Capital Management

Autonomyo provides mobility devices for disabled persons. It helps people with neurological gait disorders to walk again. The lower limb exoskeleton enables people with muscular and neurological deficiencies to walk.

Funding rounds

• Nov 2025Seed$1.6M
• Dec 2021Conventional Debt—

Founders & team

Amalric OrtliebCTO and co-founderFabian BischofCo-Founder

Investors

FIT, Venture Kick

Developer of medical devices for the treatment of lymphatic diseases. The company offers "Lymph Drain" a catheter system implanted subcutaneously that intended to recirculate lymph inside the patient body, re-establishing the physiological fluid equilibrium.

Funding rounds

• Oct 2024Series B$19.6M
• Jul 2022Grant (prize money)$51.1K
• Dec 2020Series A—
• Sep 2019Grant (prize money)$2M

Founders & team

Marco PisanoCo-Founder & CEOValentina TriaccaCo-Founder & COO

Investors

Venture Kick, HTGF, EIT Health, LIVEventures, Panakes Partners, TechWald Holding